News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,294 Results
Type
Article (43412)
Company Profile (283)
Press Release (702572)
Multimedia
Podcasts (135)
Webinars (29)
Section
Business (210961)
Career Advice (2088)
Deals (36443)
Drug Delivery (138)
Drug Development (82711)
Employer Resources (175)
FDA (16770)
Job Trends (15374)
News (355246)
Policy (33374)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2720)
Accelerated approval (46)
Adcomms (28)
Allergies (173)
Alliances (52679)
ALS (209)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (456)
Approvals (17123)
Artificial intelligence (684)
Autoimmune disease (270)
Automation (56)
Bankruptcy (369)
Best Places to Work (11948)
BIOSECURE Act (21)
Biosimilars (226)
Biotechnology (185)
Bladder cancer (186)
Brain cancer (73)
Breast cancer (746)
Cancer (5817)
Cardiovascular disease (474)
Career advice (1767)
Career pathing (42)
CAR-T (329)
CDC (58)
Celiac Disease (3)
Cell therapy (892)
Cervical cancer (46)
Clinical research (71489)
Collaboration (2176)
Company closure (5)
Compensation (1357)
Complete response letters (82)
COVID-19 (2813)
CRISPR (112)
C-suite (1114)
Cystic fibrosis (156)
Data (7604)
Decentralized trials (3)
Denatured (58)
Depression (168)
Dermatology (77)
Diabetes (579)
Diagnostics (7050)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (335)
Drug pricing (212)
Drug shortages (31)
Duchenne muscular dystrophy (277)
Earnings (92255)
Editorial (67)
Employer branding (21)
Employer resources (155)
Events (122124)
Executive appointments (1101)
FDA (20436)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1752)
Gene editing (238)
Generative AI (63)
Gene therapy (721)
GLP-1 (1080)
Government (4858)
Grass and pollen (6)
Guidances (404)
Healthcare (19563)
HIV (80)
Huntington's disease (56)
IgA nephropathy (94)
Immunology and inflammation (313)
Immuno-oncology (91)
Indications (177)
Infectious disease (3160)
Inflammatory bowel disease (212)
Inflation Reduction Act (16)
Influenza (139)
Intellectual property (289)
Interviews (330)
IPO (16911)
IRA (53)
Job creations (3739)
Job search strategy (1467)
JPM (64)
Kidney cancer (19)
Labor market (98)
Layoffs (585)
Leadership (39)
Legal (8097)
Liver cancer (103)
Longevity (33)
Lung cancer (773)
Lymphoma (425)
Machine learning (60)
Management (60)
Manufacturing (1039)
MASH (187)
Medical device (14185)
Medtech (14288)
Mergers & acquisitions (20741)
Metabolic disorders (1503)
mRNA (218)
Multiple sclerosis (186)
NASH (19)
Neurodegenerative disease (425)
Neuropsychiatric disorders (115)
Neuroscience (3348)
Neurotech (1)
NextGen: Class of 2026 (6839)
Non-profit (4740)
Now hiring (76)
Obesity (711)
Opinion (302)
Ovarian cancer (213)
Pain (251)
Pancreatic cancer (296)
Parkinson's disease (359)
Partnered (38)
Patents (592)
Patient recruitment (652)
Peanut (63)
People (61076)
Pharmaceutical (66)
Pharmacy benefit managers (32)
Phase 1 (22326)
Phase 2 (31476)
Phase 3 (23427)
Pipeline (8048)
Policy (326)
Postmarket research (2579)
Preclinical (9495)
Press Release (67)
Prostate cancer (293)
Psychedelics (55)
Radiopharmaceuticals (329)
Rare diseases (1074)
Real estate (6180)
Recruiting (71)
Regulatory (25728)
Reports (56)
Research institute (2528)
Resumes & cover letters (363)
Rett syndrome (36)
RNA editing (24)
RSV (92)
Schizophrenia (184)
Series A (302)
Series B (217)
Service/supplier (12)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (50)
Startups (3861)
State (2)
Stomach cancer (20)
Supply chain (130)
Tariffs (92)
The Weekly (74)
Vaccines (1130)
Venture capital (114)
Weight loss (464)
Women's health (123)
Worklife (20)
Date
Today (50)
Last 7 days (802)
Last 30 days (2742)
Last 365 days (30865)
2026 (10941)
2025 (30953)
2024 (35962)
2023 (40873)
2022 (52084)
2021 (56640)
2020 (55260)
2019 (48106)
2018 (36255)
2017 (33044)
2016 (32478)
2015 (38561)
2014 (32118)
2013 (27086)
2012 (29207)
2011 (29959)
2010 (27899)
Location
Africa (781)
Alabama (97)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (41287)
Australia (6762)
California (12962)
Canada (3703)
China (1342)
Colorado (555)
Connecticut (559)
Delaware (393)
Europe (90819)
Florida (1947)
Georgia (420)
Hawaii (3)
Idaho (67)
Illinois (1048)
India (91)
Indiana (597)
Iowa (24)
Japan (529)
Kansas (131)
Kentucky (52)
Louisiana (40)
Maine (87)
Maryland (1563)
Massachusetts (9295)
Michigan (357)
Minnesota (708)
Mississippi (7)
Missouri (147)
Montana (34)
Nebraska (29)
Nevada (143)
New Hampshire (87)
New Jersey (3413)
New Mexico (30)
New York (3411)
North Carolina (1704)
North Dakota (10)
Northern California (6448)
Ohio (391)
Oklahoma (25)
Oregon (42)
Pennsylvania (2607)
Puerto Rico (28)
Rhode Island (50)
South America (1148)
South Carolina (87)
South Dakota (2)
Southern California (5113)
Tennessee (210)
Texas (2085)
United States (46048)
Utah (387)
Vermont (1)
Virginia (316)
Washington D.C. (81)
Washington State (1062)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
746,294 Results for "llr partners inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TruTechnologies Secures Significant Growth Investment From LLR Partners
May 28, 2025
·
3 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25
April 6, 2026
·
1 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Vaccines
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a Phase 3 trial—but failed to hit a predetermined confidence interval.
March 23, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics
April 20, 2026
·
8 min read
Press Releases
Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada
April 13, 2026
·
2 min read
Press Releases
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
March 19, 2026
·
4 min read
Press Releases
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program
March 3, 2026
·
19 min read
Press Releases
Pfizer Becomes Newest Partner Added to BaseLaunch’s Biotech Venture Incubator
February 10, 2026
·
2 min read
Weight loss
Regeneron’s Weight Loss Partner Hansoh Delivers Much-Needed Phase 3 Win in China
Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer of hope for a pipeline in desperate need of reinvigoration.
March 9, 2026
·
2 min read
·
Annalee Armstrong
1 of 74,630
Next
